Bioequivalence Study of Sulfadoxine/Pyrimethamine 500/25 mg Dispersible Tablet
Phase 1
Not yet recruiting
- Conditions
- Fasting
- Interventions
- First Posted Date
- 2024-07-26
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Swiss Pharma Nigeria Limited
- Target Recruit Count
- 46
- Registration Number
- NCT06522763
- Locations
- 🇯🇴
International Pharmaceutical Research Center (IPRC) Queen Rania Street - Sport City Circle,, Amman, Jordan
© Copyright 2025. All Rights Reserved by MedPath